IP Library Assignment 033447/0029
Patent Assignment
Reel/Frame 033447/0029

Change of Name

Recorded: 2014-07-30 Pages: 4
Assignor
KINDEX THERAPEUTICS, LLC
Executed: 2014-03-04
Assignee
KINDEX PHARMACEUTICALS, INC.
800 FIFTH AVENUE, SUITE 4100, SEATTLE, WASHINGTON, 98104
Covered Properties (2)
Cis 3,4-Dihydroxy-2-(3-Methylbutanoyl)-5-(3-Methylbutyl)-4-(4-Methylpentanoyl)Cyclopent-2-En-1-One Derivatives, Substantially Enantiomerically Pure Compositions and Methods
Patent: 8,410,178 →
Application: 13/284,852 →
Publication: US 2012/0108671
Cis, 3,4-Dihydroxy-2-(3-Methylbutanoyl)-5-(3-Methylbutyl)-4-(4-Methylpentanoyl)Cyclopent-2-En-1-One Derivatives, Substantially Enantiomerically Pure Compositions and Methods
Patent: 8,410,179 →
Application: 13/420,062 →
Publication: US 2013/0018105
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 17, 2012
From: CARROLL, BRIAN J.; DARLAND, GARY; DESAI, ANURADHA; KONDA, VEERA
To: KINDEX THERAPEUTICS, LLC
Reel/Frame 027542/0143 →
Assignment of Assignor's Interest Dec 3, 2012
From: CARROLL, BRIAN J.; DARLAND, GARY; DESAI, ANURADHA; KONDA, VEERA
To: KINDEX THERAPEUTICS, LLC
Reel/Frame 029392/0144 →